HomeInsightsPB

Vista Pharmaceuticals Ltd PB Ratio

Vista Pharmaceuticals Ltd PB Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

2.4 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Vista Pharmaceuticals Ltd

NSE: VISTAPHARMA

PB

1.5

Last updated on: Nov 07, 2024

Key Highlights

  • The P/B Ratio of Vista Pharmaceuticals Ltd is 1.5 as of 07 Nov 24.
  • The P/B Ratio of Vista Pharmaceuticals Ltd changed from 1 on March 2022 to 1.4 on March 2024 . This represents a CAGR of 11.87% over 3 years. .

Historical P/B Ratio of Vista Pharmaceuticals Ltd

No data available

Company Fundamentals for Vista Pharmaceuticals Ltd

Market Cap

49 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

1.5

Day’s High *

13.3

Day’s Low

12.9

DTE *

0.2

ROE *

-11.2

52 Week High

19.32

52 Week Low

10.43

ROCE *

-8.2

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Vista Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 202412.85
06 Nov 202412.79
05 Nov 202412.52
04 Nov 202412.75
01 Nov 202413.1
31 Oct 202412.68
30 Oct 202412.33
29 Oct 202412.5
28 Oct 202412.45
25 Oct 202411.87

SWOT Analysis Of Vista Pharmaceuticals Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Vista Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Vista Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Vista Pharmaceuticals Ltd149
Sun Pharmaceuticals Industries Ltd984,29,841
Divis Laboratories Ltd5071,58,179
Cipla Ltd3601,27,063
Mankind Pharma Ltd2691,09,234
Dr Reddys Laboratories Ltd3221,07,398

Key Valuation Metric of Vista Pharmaceuticals Ltd

Share Price

₹13

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Vista Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Vista Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Vista Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Vista Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Vista Pharmaceuticals Ltd News Hub

News

Vista Pharmaceuticals to conduct AGM

Vista Pharmaceuticals announced that the 33th Annual General Meeting (AGM) of the company ...

Read more

10 Sep 202410:41

News

Vista Pharmaceuticals to discuss results

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

06 Aug 202414:28

News

Vista Pharmaceuticals announces board meeting date

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 M...

Read more

24 May 202416:36

News

Vista Pharmaceuticals to hold EGM

Vista Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

14 Feb 202416:53

News

Vista Pharmaceuticals to hold board meeting

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 F...

Read more

03 Feb 202416:44

News

Vista Pharmaceuticals to convene board meeting

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 N...

Read more

06 Nov 202315:30

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Vista Pharmaceuticals Ltd

What is the PB ratio of Vista Pharmaceuticals Ltd?

The current PB ratio of Vista Pharmaceuticals Ltd is 1.47. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Vista Pharmaceuticals Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Vista Pharmaceuticals Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Vista Pharmaceuticals Ltd calculated?

The PB ratio of Vista Pharmaceuticals Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Vista Pharmaceuticals Ltd?

A high PB ratio suggests that Vista Pharmaceuticals Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Vista Pharmaceuticals Ltd?

A low PB ratio of Vista Pharmaceuticals Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Vista Pharmaceuticals Ltd PB Ratio change over time?

Yes, the PB ratio of Vista Pharmaceuticals Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*